Chiron Capital Management’s VivoSim Labs VIVS Stock Holding History

Chiron Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13	Closed	-$1K	–	463
2020 Q3	$1K	Buy	+13	New	+$1.67K	﹤0.01%	489

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $100M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Chiron Capital Management's VIVS Position: Q4 2020 in Review

Chiron Capital Management sold out of VivoSim Labs (VIVS) in Q4 2020, closing a stake of 13 shares — an estimated $1K sold.

Chiron Capital Management first reported a position in VIVS in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 46 funds tracked by Wall St. Rank hold VIVS as of Q4 2020.

Chiron Capital Management reported no remaining VivoSim Labs position as of Q4 2020 after selling out during the quarter.
Chiron Capital Management sold 13 VivoSim Labs shares in Q4 2020, an estimated $1K.
Chiron Capital Management first reported a position in VivoSim Labs in Q3 2020 and held it in 1 quarter.
Chiron Capital Management's VivoSim Labs position peaked at $1K in Q3 2020.
46 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2020.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.